Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
Parent Terms Term With Siblings Child Terms
5-aza-2′-deoxycytidine 
5-bromo-2'-deoxyuridine 
5-fluorouracil 
afatinib 
Allyl isothiocyanate 
bardoxolone 
bleomycin 
BTB14431 
cisplatin +  
clodronic acid +  
curcumin 
cyclophosphamide 
An experimental condition in which the main influencing factor is cyclophosphamide (CP), an antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma.
cyclosporine A 
dexamethasone +   
diallyl trisulfide 
diethylstilbestrol  
doxorubicin +  
emodin 
enrofloxacin +  
epigallocatechin-3-gallate 
everolimus 
floxuridine +  
flutamide 
gefitinib 
gingerol 
isoliensinine 
lapatinib 
letrozole 
luteolin 
megestrol 
nintedanib 
oxaliplatin 
paclitaxel 
perhexiline maleate 
phloretin 
phosphoramidon 
puromycin 
sanguinarine 
sorafenib 
spiroplatin 
sunitinib 
taurolidine 
troglitazone 
UNC0638 
urethane 
vinblastine 

Synonyms
Exact Synonyms: CP ;   cytophosphane
Xrefs: CHEBI:4027 ;   MESH:D003520
Definition Sources: https://en.wikipedia.org/wiki/Cyclophosphamide, MESH:D003520

paths to the root